Woodmont Investment Counsel’s Harvard Bioscience HBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-61,315	Closed	-$195K	–	179
2018 Q4	$195K	Hold	61,315	–	–	0.05%	173
2018 Q3	$322K	Sell	61,315 -33,605	-35%	-$176K	0.09%	136
2018 Q2	$508K	Sell	94,920 -17,700	-16%	-$94.7K	0.14%	119
2018 Q1	$563K	Sell	112,620 -63,471	-36%	-$317K	0.16%	118
2017 Q4	$581K	Sell	176,091 -1,400	-0.8%	-$4.62K	0.15%	121
2017 Q3	$666K	Sell	177,491 -116,203	-40%	-$436K	0.18%	115
2017 Q2	$749K	Sell	293,694 -17,108	-6%	-$43.6K	0.21%	105
2017 Q1	$808K	Sell	310,802 -13,375	-4%	-$34.8K	0.23%	106
2016 Q4	$989K	Buy	324,177 +61,660	+23%	+$188K	0.28%	94
2016 Q3	$714K	Buy	262,517 +83,756	+47%	+$228K	0.2%	116
2016 Q2	$511K	Sell	178,761 -51,451	-22%	-$147K	0.15%	133
2016 Q1	$695K	Sell	230,212 -125,805	-35%	-$380K	0.21%	109
2015 Q4	$1.24M	Buy	356,017 +159,048	+81%	+$552K	0.36%	79
2015 Q3	$745K	Buy	196,969 +35,241	+22%	+$133K	0.23%	107
2015 Q2	$922K	Sell	161,728 -48,441	-23%	-$276K	0.27%	96
2015 Q1	$1.22M	Sell	210,169 -79,721	-28%	-$464K	0.38%	77
2014 Q4	$1.64M	Sell	289,890 -11,700	-4%	-$66.4K	0.5%	64
2014 Q3	$1.23M	Sell	301,590 -10,149	-3%	-$41.5K	0.35%	87
2014 Q2	$1.42M	Buy	311,739 +107,605	+53%	+$489K	0.4%	80
2014 Q1	$968K	Buy	204,134 +13,800	+7%	+$65.4K	0.28%	108
2013 Q4	$895K	Buy	190,334 +67,886	+55%	+$319K	0.27%	111
2013 Q3	$488K	Sell	122,448 -11,457	-9%	-$45.7K	0.18%	126
2013 Q2	$477K	Buy	+133,905	New	+$477K	0.16%	142